CA2411694C - Furin polypeptides with improved characteristics - Google Patents
Furin polypeptides with improved characteristics Download PDFInfo
- Publication number
- CA2411694C CA2411694C CA2411694A CA2411694A CA2411694C CA 2411694 C CA2411694 C CA 2411694C CA 2411694 A CA2411694 A CA 2411694A CA 2411694 A CA2411694 A CA 2411694A CA 2411694 C CA2411694 C CA 2411694C
- Authority
- CA
- Canada
- Prior art keywords
- furin
- amino acids
- furin polypeptide
- modified
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21075—Furin (3.4.21.75)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6454—Dibasic site splicing serine proteases, e.g. kexin (3.4.21.61); furin (3.4.21.75) and other proprotein convertases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/592,480 US6596526B1 (en) | 2000-06-09 | 2000-06-09 | Furin polypeptides with improved characteristics |
US09/592,480 | 2000-06-09 | ||
PCT/EP2001/005991 WO2001094383A2 (en) | 2000-06-09 | 2001-05-25 | Mutated furin polypeptides having improved characteristics |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2411694A1 CA2411694A1 (en) | 2001-12-13 |
CA2411694C true CA2411694C (en) | 2013-11-19 |
Family
ID=24370816
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2411694A Expired - Lifetime CA2411694C (en) | 2000-06-09 | 2001-05-25 | Furin polypeptides with improved characteristics |
Country Status (9)
Country | Link |
---|---|
US (1) | US6596526B1 (de) |
EP (1) | EP1294864B1 (de) |
JP (3) | JP5591432B2 (de) |
AT (1) | ATE320485T1 (de) |
AU (2) | AU7843101A (de) |
CA (1) | CA2411694C (de) |
DE (1) | DE60117998T2 (de) |
ES (1) | ES2260255T3 (de) |
WO (1) | WO2001094383A2 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6596526B1 (en) * | 2000-06-09 | 2003-07-22 | Baxter Aktiengesellschaft | Furin polypeptides with improved characteristics |
US8263563B2 (en) * | 2004-07-23 | 2012-09-11 | Robert E. Smith | Furin inhibitors |
US20060094104A1 (en) | 2004-10-29 | 2006-05-04 | Leopold Grillberger | Animal protein-free media for cultivation of cells |
PL2522717T3 (pl) * | 2006-01-04 | 2014-08-29 | Baxalta Inc | Pożywki do hodowli komórkowych wolne od oligopeptydów |
ES2735173T3 (es) * | 2007-12-31 | 2019-12-16 | Baxalta GmbH | Furina recombinante sustancialmente libre de proteína animal y métodos para producir la misma |
US8241623B1 (en) | 2009-02-09 | 2012-08-14 | David Bermudes | Protease sensitivity expression system |
EP2569005A1 (de) | 2010-05-12 | 2013-03-20 | INSERM - Institut National de la Santé et de la Recherche Médicale | Furin und biologisch aktive derivate davon zur verwendung bei der vorbeugung oder behandlung einer entzündungskrankheit |
WO2012122611A1 (en) * | 2011-03-11 | 2012-09-20 | Universidade De São Paulo - Usp | Method for the production of recombinant human factor viii |
KR102050609B1 (ko) | 2011-06-02 | 2019-11-29 | 박스알타 인코퍼레이티드 | 재조합 퓨린의 제형 |
AR102048A1 (es) * | 2014-08-12 | 2017-02-01 | Baxalta Inc | Producción del factor x completamente procesado y funcional en un sistema de expresión de mamífero de secreción de furina |
CA3068121A1 (en) | 2017-06-23 | 2018-12-27 | Baxalta Incorporated | Purification of factor viii subspecies |
CN117756926B (zh) * | 2023-12-26 | 2024-06-07 | 广东普言生物科技有限公司 | 一种重组ⅩⅦ型胶原蛋白Pro.C17及其制备方法和应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69032284T2 (de) | 1989-03-21 | 1998-10-08 | Vical, Inc., San Diego, Calif. | Expression von exogenen polynukleotidsequenzen in wirbeltieren |
NL9000917A (nl) | 1989-10-25 | 1991-05-16 | Holland Biotechnology | Farmaceutisch preparaat met endoproteolytische activiteit; werkwijze voor endoproteolytische processing van (precursor) eiwitten en voor de (micro) biologische bereiding van eiwitten. |
ATE158816T1 (de) * | 1990-11-26 | 1997-10-15 | Genetics Inst | Expression von pace in wirtszellen und verfahren zu dessen verwendung |
US5298422A (en) | 1991-11-06 | 1994-03-29 | Baylor College Of Medicine | Myogenic vector systems |
AT404838B (de) * | 1995-11-24 | 1999-03-25 | Immuno Ag | Herstellung von proteinen aus pro-proteinen durch fusionsproteine abgeleitet von furin oder furinanalogen |
JPH09295945A (ja) | 1996-04-30 | 1997-11-18 | Hoechst Yakuhin Kogyo Kk | 成熟型骨誘導因子の製造方法 |
US6596526B1 (en) * | 2000-06-09 | 2003-07-22 | Baxter Aktiengesellschaft | Furin polypeptides with improved characteristics |
-
2000
- 2000-06-09 US US09/592,480 patent/US6596526B1/en not_active Expired - Lifetime
-
2001
- 2001-05-25 AU AU7843101A patent/AU7843101A/xx active Pending
- 2001-05-25 DE DE60117998T patent/DE60117998T2/de not_active Expired - Lifetime
- 2001-05-25 AU AU2001278431A patent/AU2001278431B2/en not_active Ceased
- 2001-05-25 EP EP01956445A patent/EP1294864B1/de not_active Expired - Lifetime
- 2001-05-25 CA CA2411694A patent/CA2411694C/en not_active Expired - Lifetime
- 2001-05-25 ES ES01956445T patent/ES2260255T3/es not_active Expired - Lifetime
- 2001-05-25 WO PCT/EP2001/005991 patent/WO2001094383A2/en active IP Right Grant
- 2001-05-25 JP JP2002501931A patent/JP5591432B2/ja not_active Expired - Fee Related
- 2001-05-25 AT AT01956445T patent/ATE320485T1/de active
-
2011
- 2011-06-27 JP JP2011142374A patent/JP2011182802A/ja not_active Withdrawn
-
2014
- 2014-06-03 JP JP2014114538A patent/JP2014155506A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
DE60117998D1 (de) | 2006-05-11 |
JP2014155506A (ja) | 2014-08-28 |
JP2011182802A (ja) | 2011-09-22 |
AU7843101A (en) | 2001-12-17 |
DE60117998T2 (de) | 2006-11-16 |
WO2001094383A3 (en) | 2002-11-21 |
AU2001278431B2 (en) | 2006-08-10 |
EP1294864A2 (de) | 2003-03-26 |
ES2260255T3 (es) | 2006-11-01 |
JP5591432B2 (ja) | 2014-09-17 |
CA2411694A1 (en) | 2001-12-13 |
US6596526B1 (en) | 2003-07-22 |
ATE320485T1 (de) | 2006-04-15 |
WO2001094383A2 (en) | 2001-12-13 |
JP2004508015A (ja) | 2004-03-18 |
EP1294864B1 (de) | 2006-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2014155506A (ja) | 改良された特性を有するフリンポリペプチド | |
Lind et al. | Novel forms of B‐domain‐deleted recombinant factor VIII molecules: construction and biochemical characterization | |
Seidah et al. | The family of subtilisin/kexin like pro-protein and pro-hormone convertases: divergent or shared functions | |
Pei et al. | Furin-dependent intracellular activation of the human stromelysin-3 zymogen | |
MAINS et al. | PACE4: a subtilisin-like endoprotease with unique properties | |
EP1127154B1 (de) | Verfahren zur herstellung von faktor vii | |
US6562598B1 (en) | Factor X deletion mutants and analogues thereof | |
CA2191053C (en) | A fusion protein comprising a furin derivative or a derivative of a furin analogue and a heterlogous sequence | |
AU2001278431A1 (en) | Mutated furin polypeptides having improved characteristics | |
Plaimauer et al. | ‘Shed’furin: mapping of the cleavage determinants and identification of its C-terminus | |
Creemers et al. | Proprotein processing activity and cleavage site selectivity of the Kex2‐like endoprotease PACE4 | |
US6958322B1 (en) | Factor X analog with an improved ability to be activated | |
Takahashi et al. | Sequence requirements for endoproteolytic processing of precursor proteins by furin: transfection and in vitro experiments | |
Laprise et al. | Enhanced TGFβ1 maturation in high five cells coinfected with recombinant baculovirus encoding the convertase furin/pace: improved technology for the production of recombinant proproteins in insect cells | |
Kido et al. | Processing of proendothelin‐1 at the C‐terminus of big endothelin‐1 is essential for proteolysis by endothelin‐converting enzyme‐1 in vivo | |
Himmelspach et al. | Recombinant human factor X: high yield expression and the role of furin in proteolytic maturation in vivo and in vitro | |
HOSPITAL et al. | N-arginine dibasic convertase (nardilysin) isoforms are soluble dibasic-specific metalloendopeptidases that localize in the cytoplasm and at the cell surface | |
Denault et al. | Comparative characterization of two forms of recombinant human SPC1 secreted from Schneider 2 cells | |
Preininger et al. | Strategies for recombinant Furin employment in a biotechnological process: complete target protein precursor cleavage | |
DELWEL et al. | Identification of the cleavage sites in the α 6A integrin subunit: structural requirements for cleavage and functional analysis of the uncleaved α 6A β 1 integrin | |
Bailyes et al. | Differences between the catalytic properties of recombinant human PC2 and endogenous rat PC2 | |
Demasi et al. | Enhanced Proteolytic processing of recombinant human coagulation factor VIII B-domain variants by recombinant Furins | |
Coates et al. | Posttranslational maturation of the prohormone convertase SPC3 in vitro | |
EP1136553A1 (de) | Herstellung von rekombinanten Blutgerinnungsfaktoren in humanen Zellinien | |
Stanton et al. | Processing and expression of rat and human clotting factor-X-encoding cDNAs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |
Effective date: 20210525 |